NCOA2 and obesity due to melanocortin 4 receptor deficiency: As we illustrated in network pharmacologic analysis (Fig 6), these compounds might work in combination with other active compounds to attenuate obesity via modulating major targets including PTGS2, ADRB2, and NCOA2.